Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket
Kent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors
Clarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Scientific Reports
|
August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site
Eric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Journal of Medicinal Chemistry
|
May 26, 2007
Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension
Gui-Dong Zhu, Viraj B Gandhi, Jianchun Gong, et al.
Anti-Cancer Drugs
|
October 14, 2005
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies
Wen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, et al.
Communications Chemistry
|
August 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex
Qi Hao, Manoj K Rathinaswamy, Kelly L Klinge, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
Yujia Dai, Yan Guo, Robin R Frey, et al.
Journal of Medicinal Chemistry
|
December 30, 2020
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design
Justin D Dietrich, Kenton L Longenecker, Noel S Wilson, et al.
Journal of Medicinal Chemistry
|
March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor
Yujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Molecular Cancer Therapeutics
|
June 16, 2005
Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo
Yan Luo, Alexander R Shoemaker, Xuesong Liu, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket
Kent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors
Clarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Scientific Reports
|
August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site
Eric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Journal of Medicinal Chemistry
|
May 26, 2007
Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension
Gui-Dong Zhu, Viraj B Gandhi, Jianchun Gong, et al.
Anti-Cancer Drugs
|
October 14, 2005
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies
Wen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, et al.
Communications Chemistry
|
August 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex
Qi Hao, Manoj K Rathinaswamy, Kelly L Klinge, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
Yujia Dai, Yan Guo, Robin R Frey, et al.
Journal of Medicinal Chemistry
|
December 30, 2020
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design
Justin D Dietrich, Kenton L Longenecker, Noel S Wilson, et al.
Journal of Medicinal Chemistry
|
March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor
Yujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Molecular Cancer Therapeutics
|
June 16, 2005
Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo
Yan Luo, Alexander R Shoemaker, Xuesong Liu, et al.
Page
of 4